Jennifer Jackson
Director/Board Member at ONCOPEPTIDES AB
Profile
Jennifer A.
Jackson is an Independent Director at Oncopeptides AB, a Director at TESARO UK Ltd., and a Member of the American Society of Clinical Oncology, Inc. She previously worked as an Executive Director-Regulatory Affairs at Bristol Myers Squibb Co., a Scientist at Repligen Corp., a Vice President-Regulatory Affairs at Vertex Pharmaceuticals, Inc., a Vice President-Regulatory Affairs at Biogen, Inc., a Senior Vice President-Regulatory Affairs at Cubist Pharmaceuticals LLC, a Vice President-Regulatory & Clinical Compliance at Bioverativ Therapeutics, Inc., and a Senior VP-Regulatory Affairs & Quality Assurance at Tesaro, Inc. Dr. Jackson received her undergraduate degree from The Reed Institute and her doctorate from Cornell University.
Jennifer Jackson active positions
| Companies | Position | Start |
|---|---|---|
| ONCOPEPTIDES AB | Director/Board Member | 2018-12-04 |
TESARO UK Ltd.
 TESARO UK Ltd. Medical DistributorsDistribution Services Part of GSK Plc, TESARO UK Ltd. distributes oncology products. The private company is based in London, UK. Founded in 2011. | Director/Board Member | 2015-06-29 |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Corporate Officer/Principal | - |
Former positions of Jennifer Jackson
| Companies | Position | End |
|---|---|---|
Bioverativ Therapeutics, Inc.
 Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | General Counsel | 2010-12-31 |
| VERTEX PHARMACEUTICALS INCORPORATED | General Counsel | - |
| TESARO INC | General Counsel | - |
| BRISTOL-MYERS SQUIBB COMPANY | General Counsel | - |
| BIOGEN INC. | General Counsel | - |
Training of Jennifer Jackson
| The Reed Institute | Undergraduate Degree |
| Cornell University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 5 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| REPLIGEN CORPORATION | Health Technology |
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| BIOGEN INC. | Health Technology |
| ONCOPEPTIDES AB | Health Technology |
| Private companies | 5 |
|---|---|
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA. | Health Technology |
Bioverativ Therapeutics, Inc.
Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | Health Technology |
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA. | Health Technology |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Health Services |
TESARO UK Ltd.
TESARO UK Ltd. Medical DistributorsDistribution Services Part of GSK Plc, TESARO UK Ltd. distributes oncology products. The private company is based in London, UK. Founded in 2011. | Distribution Services |
- Stock Market
- Insiders
- Jennifer Jackson
